NEK4 suppresses cell proliferation in BT20 triple-negative breast cancer cells by diminishing expression of cell cycle genes, while its depletion mitigates proliferation in other cell lines is a research paper published in Frontiers in Oncology (2025). On theSindex it has a DataRank of 0.188. It has been cited 2 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0.0228
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
NIGMS NIH HHS
Grant: P20 GM103451
National Institutes of Health
Grant: 5U54CA132381-04
Planning and Evaluation Core
National Institutes of Health
Grant: 3P20GM103451-21S1
Deep sequencing SARS-CoV-2 samples from New Mexico to interrogate immunological selection on genetic variants
National Institutes of Health
Grant: 2U54CA132383-11
1/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch
Fields of Study
Keywords
Data from: NEK4 suppresses cell proliferation in BT20 triple-negative breast cancer cells by diminishing expression of cell cycle genes, while its depletion mitigates proliferation in other cell lines